Multicenter Phase Ii Study of Moderate Low-Dose Radiotherapy in Indolent Non-Hodgkin Lymphoma: CLCG-iNHL-01 Protocol

Author:

Gao Lin-Rui1ORCID,Wang Xinyue1,Xia Changfa2,Song Yong-Wen1,Wang Liang3,Li Xin3,Yang Yong4,Cao Jian-Zhong5,Chen Ke6,Zhong Qiu-Zi7,Gao Yuyan8,Zhou Sheng-Yu9,Feng Xiao-Li10,Wang Xiaojun10,Li Ye-Xiong1ORCID,Qi Shu-Nan1

Affiliation:

1. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China

2. Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China

3. Department of Hematology, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730, China

4. Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350108, China

5. Shanxi Cancer Hospital & the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030013, China

6. Department of Radiochemotherapy, The Affiliated People’s Hospital of Ningbo University, Ningbo, Zhejiang, 315100, China

7. Department of Radiation Oncology, Beijing Hospital, National Geriatric Medical Center, Beijing, 100005, China

8. The Department of Radiotherapy, Beijing Luhe Hospital, Capital Medical University, Beijing, 101199, China

9. Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, 100021, China

10. Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, 100021, China

Publisher

Informa UK Limited

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Alzheimer's disease and low-dose radiation therapy: A new hope;Radiation Medicine and Protection;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3